Alan Perlman
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
-
- Advanced Glycation End Products research
Papers in
-
- Chronic Kidney Disease and Diabetes 4
- Renal Diseases and Glomerulopathies 3
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- James M. Chevalier (3 shared papers)Surya V. Seshan (3 shared papers)Raymond L. Sherman (1 shared paper)Francis X. Farrell (1 shared paper)Choli Hartono (2 shared papers)Patrick Wilkinson (1 shared paper)Thomas S. Parker (2 shared papers)Hao Liu (1 shared paper)
- Journals
- Kidney International Reports (2 papers)American Speech (1 paper)Clinical Nephrology (1 paper)Journal of Ultrasound in Medicine (1 paper)American Journal of Therapeutics (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Alan Perlman
10 papers receiving 184 citations
Peers
Comparison fields: 5 of 60
- Nephrology 100
- Clinical Biochemistry 15
- Immunology 41
- Hematology 18
- Pathology and Forensic Medicine 26
Countries citing papers authored by Alan Perlman
This map shows the geographic impact of Alan Perlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Perlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Perlman more than expected).
Fields of papers citing papers by Alan Perlman
This network shows the impact of papers produced by Alan Perlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Perlman. The network helps show where Alan Perlman may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Perlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Serum Inflammatory and Immune Mediators Are Elevated in Early Stage Diabetic Nephropathy. | 2015 | 83 |
| 2 | 2018 | 49 | |
| 3 | Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase. | 2004 | 22 |
| 4 | 2017 | 21 | |
| 5 | 1969 | 5 | |
| 6 | 2015 | 3 | |
| 7 | 2007 | 2 | |
| 8 | 2014 | 2 | |
| 9 | 2021 | 1 | |
| 10 | 2013 | 1 | |
| 11 | Utility of Cystatin C in the Setting of Urinoma. | 2018 | 0 |
About Alan Perlman
Alan Perlman is a scholar working on Nephrology, Genetics, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Transplantation, having authored 11 papers that have together received 189 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Lexicography and Language Studies (1 paper), Apelin-related biomedical research (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Nephrology (100 citations), Clinical Biochemistry (15 citations), Immunology (41 citations), Hematology (18 citations) and Pathology and Forensic Medicine (26 citations). Alan Perlman has collaborated with scholars based in United States and Germany. Frequent co-authors include James M. Chevalier, Surya V. Seshan, Raymond L. Sherman, Francis X. Farrell, Choli Hartono, Patrick Wilkinson, Thomas S. Parker, Hao Liu, Daniel M. Levine and David Serur. Their work appears in journals such as Kidney International Reports, American Speech, Clinical Nephrology, Journal of Ultrasound in Medicine and American Journal of Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.